These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1387601

  • 21. Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting.
    Bull World Health Organ; 1986; 64(3):375-82. PubMed ID: 2945666
    [Abstract] [Full Text] [Related]

  • 22. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
    Rosenfield A, Maine D, Rochat R, Shelton J, Hatcher RA.
    JAMA; 1983 Jun 03; 249(21):2922-8. PubMed ID: 6221125
    [Abstract] [Full Text] [Related]

  • 23. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.
    Pardthaisong T, Gray RH, McDaniel EB.
    Lancet; 1980 Mar 08; 1(8167):509-12. PubMed ID: 6102234
    [Abstract] [Full Text] [Related]

  • 24. Depot medroxyprogesterone acetate and breast cancer. A pooled analysis of the World Health Organization and New Zealand studies.
    Skegg DC, Noonan EA, Paul C, Spears GF, Meirik O, Thomas DB.
    JAMA; 1995 Mar 08; 273(10):799-804. PubMed ID: 7861575
    [Abstract] [Full Text] [Related]

  • 25. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan 08; 25(1):1-11. PubMed ID: 6460593
    [Abstract] [Full Text] [Related]

  • 26. Depo medroxyprogesterone acetate (DMPA) and combined oral contraceptives and cervical carcinoma in-situ in women aged 50 years and under.
    Hoyo C, Cousins DS, Bisgrove EZ, Gaines MM, Schwingl PJ, Fortney JA.
    West Indian Med J; 2004 Dec 08; 53(6):406-12. PubMed ID: 15816269
    [Abstract] [Full Text] [Related]

  • 27. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul 08; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 28. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M, Guarnaccia M, Alon J, Wiley J.
    Fam Plann Perspect; 1996 Jul 08; 28(4):174-8. PubMed ID: 8853283
    [Abstract] [Full Text] [Related]

  • 29. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
    Thomas DB, Ray RM.
    Am J Epidemiol; 1996 Aug 01; 144(3):281-9. PubMed ID: 8686697
    [Abstract] [Full Text] [Related]

  • 30. Steroid contraceptive use and pregnancy outcome.
    Pardthaisong T, Gray RH, McDaniel EB, Chandacham A.
    Teratology; 1988 Jul 01; 38(1):51-8. PubMed ID: 2845595
    [Abstract] [Full Text] [Related]

  • 31. Depot medroxyprogesterone acetate contraception in women with medical problems.
    Frederiksen MC.
    J Reprod Med; 1996 May 01; 41(5 Suppl):414-8. PubMed ID: 8725704
    [Abstract] [Full Text] [Related]

  • 32. Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate.
    Bahamondes MV, Castro S, Marchi NM, Marcovici M, Andrade LA, Fernandes A, Bahamondes L.
    Contraception; 2014 Aug 01; 90(2):117-22. PubMed ID: 24613369
    [Abstract] [Full Text] [Related]

  • 33. Long-term effects of depot-medroxyprogesterone acetate on lipoprotein metabolism.
    Garza-Flores J, De la Cruz DL, Valles de Bourges V, Sanchez-Nuncio R, Martinez M, Fuziwara JL, Pérez-Palacios G.
    Contraception; 1991 Jul 01; 44(1):61-71. PubMed ID: 1832626
    [Abstract] [Full Text] [Related]

  • 34. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
    Orr-Walker BJ, Evans MC, Ames RW, Clearwater JM, Cundy T, Reid IR.
    Clin Endocrinol (Oxf); 1998 Nov 01; 49(5):615-8. PubMed ID: 10197077
    [Abstract] [Full Text] [Related]

  • 35. Bone density in long term users of depot medroxyprogesterone acetate.
    Gbolade B, Ellis S, Murby B, Randall S, Kirkman R.
    Br J Obstet Gynaecol; 1998 Jul 01; 105(7):790-4. PubMed ID: 9692421
    [Abstract] [Full Text] [Related]

  • 36. Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user.
    Dahlberg K.
    Int J Gynaecol Obstet; 1982 Feb 01; 20(1):43-8. PubMed ID: 6126406
    [Abstract] [Full Text] [Related]

  • 37. Depot medroxyprogesterone acetate: a risk factor for cervical stenosis after loop electrosurgical excisional procedure management of cervical intraepithelial neoplasia?
    Martirosian TE, Smith SC, Baras AS, Darracott MM.
    J Low Genit Tract Dis; 2010 Jan 01; 14(1):37-42. PubMed ID: 20040834
    [Abstract] [Full Text] [Related]

  • 38. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis.
    Vercellini P, De Giorgi O, Oldani S, Cortesi I, Panazza S, Crosignani PG.
    Am J Obstet Gynecol; 1996 Aug 01; 175(2):396-401. PubMed ID: 8765259
    [Abstract] [Full Text] [Related]

  • 39. Depot medroxyprogesterone acetate and endometrial cancer: A multicenter case-control study.
    Kietpeerakool C, Cheewakriangkrai C, Rattanakanokchai S, Rattanalappaiboon D, Tiyayon J, Chalapati W, Tangsiriwattana T, Tangjitgamol S, Kleebkaow P, Khunamornpong S, Temtanakitpaisan A, Sribanditmongkhol N, Lumbiganon P.
    Int J Gynaecol Obstet; 2023 Oct 01; 163(1):96-102. PubMed ID: 37183712
    [Abstract] [Full Text] [Related]

  • 40. Galactorrhea in DMPA users: incidence and clinical significance.
    Gongsakdi D, Rojanasakul A.
    J Med Assoc Thai; 1986 Jan 01; 69(1):28-32. PubMed ID: 2937870
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.